Following acute or chronic liver tissue damage, hepatic stellate cells (HSC
s) undergo a process of activation toward a phenotype characterized by incr
eased proliferation, motility, contractility, and synthesis of extracellula
r matrix components. Activation of HSCs is regulated by several soluble fac
tors, including growth factors, cytokines, chemokines, and products of oxid
ative stress, as well as by extensive changes in the composition and organi
zation of the ECM. Different groups of soluble factors may be classified ac
cording to their prevalent biological effect: (a) factors promoting HSC pro
liferation and/or migration (i.e., platelet-derived growth factor, basic fi
broblast growth factor, insulin-like growth factor-1); (b) factors promotin
g fibrillar ECM accumulation, particularly transforming growth factor-beta1
; (c) factors with a prevalent contractile effect on HSCs, such as endothel
in-1, thrombin, angiotensin-Il and vasopressin, although all these agents a
lso may promote HSC proliferation; (d) proinflammatory cytokines and chemok
ines; and (e) cytokines with a prominent antiinflammatory/antifibrogenic ac
tivity, such as interleukin-10 and interferon-gamma. Additional important i
ssues are represented by the relationship between cytokine and integrin sig
naling, and by the effects of oxidative stress-related molecules on cytokin
e signaling. In the past decade the major intracellular signaling pathways
elicited by these factors in HSCs have been greatly elucidated.